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Metacortandracin and metacortandralone are new synthetic steroids that possess the
physiological activities of adrenal cortical hormones. Biological experiments indicate that
these compounds are potent anti-inflammatory agents, and that they have approximately
three to four times the activity of cortisone or hydrocortisone. Preliminary studies also
suggest that the enhanced potency of metacortandracin and metacortandralone may not be
accompanied by a proportionate increase in the severity of undesirable side effects. For
example, doses up to 50 mg. daily for 24 successive days produced a negative nitrogen
balance but did not cause retention of sodium, loss of potassium, significant elevation of
the fasting blood sugar, glycosuria or hypertension (1).
The possible value of new steroids of this type in the treatment of dermatologic diseases
seemed worthy of trial. Steroids which possess high potency and cause minimal undesirable
side effects would be particularly valuable in the treatment of desperate and ordinarily
fatal diseases in which corticosteroid therapy must often be maintained for months or years
in the face of serious complications. The purpose of the present case report is to summarize
the results of treatment with metacortandracin in one patient with pemphigus vulgaris.
CASE REPORT
H. S. a white man aged 49, of Jewish extraction, had painful superficial erosions of the
mouth for nine months prior to admission to Presbyterian Hospital. He had been treated
with antibiotic troches, astringent mouth washes, applications of silver nitrate and elimina-
tion diets with no effect. Two months before admission the patient consulted a dermatolo-
gist who prescribed cortisone, 75 to 100 mg. daily. The oral lesions improved temporarily
but subsequently relapsed and large bullous erosions appeared on the trunk, face and ex-
tremities. The patient was then given corticosteroids in doses up to 300 mg. daily, anti-
biotics, vitamins and baths of potassium permanganate, 1:10,000. His condition deterio-
rated steadily over a period of four weeks and he was admitted to the hospital for treat-
ment. Examination showed the clinical appearance of widespread pemphigus vulgaris. This
diagnosis was confirmed by biopsy of the skin lesions, Therapy with corticotropin, 25 mg.
in 1000 ml. 5% Dextrose in water intravenously over a period of six to eight hours daily, was
started. This was supplemented with cortisone by mouth, 600 mg. daily, which was in-
creased to 1000 mg. per day after the first week. New bullae continued to appear and the
patient's condition became worse. He developed widespread acneiform lesions and miliaria
and he became mentally disturbed. On the 17th hospital day, corticotropin and cortisone
were discontinued and the patient was given metacortandracin, 200 mg. per day in four
divided doses. Sodium chloride, 3 gm. daily, was added to the diet. The low salt intake and
potassium chloride, 2 to 3 gm. per day, which had been given up to then, were discontinued.
Because of the further development of pemphigus lesions the dose of metacortandracin was
increased after one week to 250 mg. daily. Within three days after this increase the forma-
tion of new bullae ceased and previous lesions began to heal.
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The metacortandracin used in this study was Meticorten. It was supplied through the
courtesy of Dr. Edward Henderson, Schering Corporation, Bloomfield, New Jersey.
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During the first eight days of metacortandracin administration the patient gained 11
pounds (5 Kg.) and the lower legs and ankles became edematous. The face became full but
the aeneiform eruption gradually subsided. The patient's appetite increased greatly and he
became euphoric and hyperactive. The mental symptoms improved greatly after chiorpro-
mazine hydrochloride (Thorazine®) 50 mg. per day was started. Discontinuation of the
added sodium chloride in the diet was followed by a spontaneous diuresis and the patient's
weight fellfrom 161 lbs. to its previous level of 150 lbs. (68.2 Kg.). Serum potassium, sodium,
glucose, carbon dioxide content, chloride, albumin, globulin, urea nitrogen and blood sugar
values remained within normal limits as they had been since the day of admission. After
seven days of therapy with metacortandracin in doses of 250 mg. per day the daily dose was
decreased by decrements of 10 mg. every 4 days. When the level of 200 mg. per day was
reached the patient was discharged from the hospital and followed on an ambulatory basis.
His skin was in excellent condition at the time of discharge but scattered oral erosions were
still present.
COMMENT
The results of treatment with rnetacortandracin in this case suggest that this steroid
may be a useful agent in the management of pemphigus vulgaris. Doses of metacortandra-
cm up to 250 mg. per day resulted in healing of the skin lesions without causing abnormali-
ties in blood chemical values. No hypertension developed. Edema of the lower legs and
ankles occurred after sodium chloride, 3 grams per day, was added to the diet but this
condition cleared spontaneously when the added salt was discontinued. Side effects ob-
served during metacortandracin administration included facial rounding, increased appe-
tite, euphoria and restlessness. An acneiform eruption induced previously with cortico-
tropin and cortisone became less noticeable during treatment with metacortandracin but
profuse sweating and a tendency toward the formation of miliaria continued.
This is a preliminary report based on the short-term observation of a single patient with
pemphigus. Nothing can yet be said about the effects of prolonged administration of this
compound. However, the administration of large doses results in a negative nitrogen bal-
ance and it may be expected that such doses, if long continued, will ultimately be asso-
ci ated with demineralization and osteoporosis.
SUMMARY
A case of pemphigus vulgaris successfully treated with metacortandracin has been pre-
sented. Daily doses up to 250 mg. per day were tolerated for a brief period of time with no
serious side effects.
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